Literature DB >> 21109473

Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma.

Carmit Levy1, Mehdi Khaled, Dimitrios Iliopoulos, Maja M Janas, Steffen Schubert, Sophie Pinner, Po-Hao Chen, Shuqiang Li, Anne L Fletcher, Satoru Yokoyama, Kenneth L Scott, Levi A Garraway, Jun S Song, Scott R Granter, Shannon J Turley, David E Fisher, Carl D Novina.   

Abstract

When it escapes early detection, malignant melanoma becomes a highly lethal and treatment-refractory cancer. Melastatin is greatly downregulated in metastatic melanomas and is widely believed to function as a melanoma tumor suppressor. Here we report that tumor suppressive activity is not mediated by melastatin but instead by a microRNA (miR-211) hosted within an intron of melastatin. Increasing expression of miR-211 but not melastatin reduced migration and invasion of malignant and highly invasive human melanomas characterized by low levels of melastatin and miR-211. An unbiased network analysis of melanoma-expressed genes filtered for their roles in metastasis identified three central node genes: IGF2R, TGFBR2, and NFAT5. Expression of these genes was reduced by miR-211, and knockdown of each gene phenocopied the effects of increased miR-211 on melanoma invasiveness. These data implicate miR-211 as a suppressor of melanoma invasion whose expression is silenced or selected against via suppression of the entire melastatin locus during human melanoma progression.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21109473      PMCID: PMC3004467          DOI: 10.1016/j.molcel.2010.11.020

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  30 in total

1.  Silencing of microRNAs in vivo with 'antagomirs'.

Authors:  Jan Krützfeldt; Nikolaus Rajewsky; Ravi Braich; Kallanthottathil G Rajeev; Thomas Tuschl; Muthiah Manoharan; Markus Stoffel
Journal:  Nature       Date:  2005-10-30       Impact factor: 49.962

2.  Tumor cell migration in three dimensions.

Authors:  Steven Hooper; John F Marshall; Erik Sahai
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

Review 3.  MITF: master regulator of melanocyte development and melanoma oncogene.

Authors:  Carmit Levy; Mehdi Khaled; David E Fisher
Journal:  Trends Mol Med       Date:  2006-08-08       Impact factor: 11.951

4.  Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.

Authors:  Keith S Hoek; Natalie C Schlegel; Patricia Brafford; Antje Sucker; Selma Ugurel; Rajiv Kumar; Barbara L Weber; Katherine L Nathanson; David J Phillips; Meenhard Herlyn; Dirk Schadendorf; Reinhard Dummer
Journal:  Pigment Cell Res       Date:  2006-08

5.  Patterns of melastatin mRNA expression in melanocytic tumors.

Authors:  J Deeds; F Cronin; L M Duncan
Journal:  Hum Pathol       Date:  2000-11       Impact factor: 3.466

6.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

7.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

8.  Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis.

Authors:  L M Duncan; J Deeds; J Hunter; J Shao; L M Holmgren; E A Woolf; R I Tepper; A W Shyjan
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

9.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

10.  Characterization of microRNA expression levels and their biological correlates in human cancer cell lines.

Authors:  Arti Gaur; David A Jewell; Yu Liang; Dana Ridzon; Jason H Moore; Caifu Chen; Victor R Ambros; Mark A Israel
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

View more
  115 in total

Review 1.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

Review 2.  Circulating epigenetic biomarkers in melanoma.

Authors:  Yu Xin; Zheng Li; Matthew T V Chan; William Ka Kei Wu
Journal:  Tumour Biol       Date:  2015-12-11

Review 3.  TRP channels in the skin.

Authors:  Balázs I Tóth; Attila Oláh; Attila Gábor Szöllősi; Tamás Bíró
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

4.  Role of TRPM in melanocytes and melanoma.

Authors:  Huazhang Guo; John Andrew Carlson; Andrzej Slominski
Journal:  Exp Dermatol       Date:  2012-09       Impact factor: 3.960

Review 5.  Pivotal MicroRNAs in Melanoma: A Mini-Review.

Authors:  Zhenjun Deng; Jingang Hao; Dongyun Lei; Yongjing He; Lechun Lu; Li He
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

6.  microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis.

Authors:  Sankhiros Babapoor; Michael Horwich; Rong Wu; Shauna Levinson; Manoj Gandhi; Hanspaul Makkar; Arni Kristjansson; Mary Chang; Soheil S Dadras
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

7.  Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing.

Authors:  Sankhiros Babapoor; Rong Wu; James Kozubek; Donna Auidi; Jane M Grant-Kels; Soheil S Dadras
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

Review 8.  miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.

Authors:  Paige E Bennett; Lynne Bemis; David A Norris; Yiqun G Shellman
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

9.  MicroRNA-211 Loss Promotes Metabolic Vulnerability and BRAF Inhibitor Sensitivity in Melanoma.

Authors:  Anupama Sahoo; Sanjaya K Sahoo; Piyush Joshi; Bongyong Lee; Ranjan J Perera
Journal:  J Invest Dermatol       Date:  2018-08-01       Impact factor: 8.551

Review 10.  Molecular and cellular pathogenesis of melanoma initiation and progression.

Authors:  Tarik Regad
Journal:  Cell Mol Life Sci       Date:  2013-03-27       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.